← Back to Search

Procedure

3D Printing + Conventional Imaging for Hip Surgery Planning

N/A
Waitlist Available
Led By Ivan Wong, Dr.
Research Sponsored by Nova Scotia Health Authority
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change in pre-op measurements compared to 24 months post-operatively
Awards & highlights

Study Summary

This trial is testing whether 3D printed models can help with planning for arthroscopic FAI surgery. Patients will be randomly assigned to either have just conventional imaging or to have a 3D printed model in addition.

Who is the study for?
This trial is for individuals with a confirmed diagnosis of cam-type femoroacetabular impingement (FAI) using radiology. It's not suitable for those who are pregnant, unable to consent, have infections, don't understand post-op care, have cancer or advanced arthritis, heterotopic ossification types III/IV, need revision surgery, nonvascular surgical sites or avascular necrosis.Check my eligibility
What is being tested?
The study compares two approaches in planning hip preservation surgery: one group uses standard imaging techniques like X-ray and MRI only; the other group gets a personalized 3D printed model based on these images as well. Patients will be randomly assigned to either group.See study design
What are the potential side effects?
Since this trial focuses on preoperative planning methods rather than medications or invasive procedures directly administered to patients, there are no direct side effects from the interventions being tested.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change in pre-op measurements compared to 24 months post-operatively
This trial's timeline: 3 weeks for screening, Varies for treatment, and change in pre-op measurements compared to 24 months post-operatively for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Measure of CAM resection
Secondary outcome measures
Differences in post-operative patient reported outcomes: EQ5D
Differences in post-operative patient reported outcomes: EQ5D-VAS
Differences in post-operative patient reported outcomes: HOS-Sport
+4 more
Other outcome measures
The number of times conventional imaging and 3D prints are referenced intra-operatively.

Trial Design

2Treatment groups
Experimental Treatment
Group I: Conventional ImagingExperimental Treatment1 Intervention
Patients in this group allocation will receive conventional preoperative imaging (X-ray, CT, and MRI) only for the use of pre-operative and intra-operative planning for their hip arthroscopy (FAI) procedure.
Group II: 3D Print + Conventional imagingExperimental Treatment1 Intervention
Patients in this group allocation will receive a 3D reconstruction of their hip in addition to conventional preoperative imaging (X-ray, CT, and MRI) only for the use of pre-operative and intra-operative planning for their hip arthroscopy (FAI) procedure.

Find a Location

Who is running the clinical trial?

Nova Scotia Health AuthorityLead Sponsor
254 Previous Clinical Trials
83,059 Total Patients Enrolled
Ivan Wong, Dr.Principal InvestigatorNova Scotia Health Authority

Media Library

3D Print + Conventional imaging (Procedure) Clinical Trial Eligibility Overview. Trial Name: NCT04505020 — N/A
Femoroacetabular Impingement Research Study Groups: 3D Print + Conventional imaging, Conventional Imaging
Femoroacetabular Impingement Clinical Trial 2023: 3D Print + Conventional imaging Highlights & Side Effects. Trial Name: NCT04505020 — N/A
3D Print + Conventional imaging (Procedure) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04505020 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is recruitment for this clinical trial ongoing?

"According to clinicaltrials.gov, this trial is not enrolling patients currently; the original posting was on January 1st 2021 and it underwent its last update in March 7th 2022. Although there are no active recruitment efforts for this study right now, 15 other trials have opened up their enrollment process."

Answered by AI
~9 spots leftby Aug 2024